Skip to main content
PharmAbcine Inc. logo

PharmAbcine Inc. — Investor Relations & Filings

Ticker · 208340 ISIN · KR7208340000 KO Manufacturing
Open in API
Filings indexed 461 across all filing types
Latest filing 2022-12-20 Regulatory Filings
Country KR South Korea
Listing KO 208340

About PharmAbcine Inc.

http://pharmabcine.com/

PharmAbcine Inc. is a clinical-stage biotechnology company specializing in the development of fully human therapeutic monoclonal antibodies (mAbs). The company focuses on creating innovative treatments for diseases with high unmet medical needs, primarily in oncology, neovascular eye diseases, and other inflammatory and vascular disorders. Utilizing its proprietary human antibody library and discovery technologies, PharmAbcine advances a pipeline of next-generation IgG-based therapeutics. The company's mission is to contribute to human health by providing novel antibody-based drugs to patients.

Recent filings

Filing Released Lang Actions
투자판단관련주요경영사항(신생혈관성 연령관련 황반변성 환자를 대상으로 PMC-403 단회 및 반복 투여 용량 증량의 안전성 및 내약성을 평가하기 위한 다기관, 공개, 제 1상 임상시험계획 승인 신청)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from a Korean company (PharmAbcine) regarding a 'Major Management Matter' (투자판단 관련 주요경영사항). It specifically details the submission of a Phase 1 clinical trial application to the Ministry of Food and Drug Safety. Since this is a formal regulatory disclosure of a material event (clinical trial application) rather than a financial report, dividend notice, or management change, it falls under the general regulatory filing category.
2022-12-20 Korean
주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure for an upcoming Annual General Meeting (AGM). It does not contain the full AGM materials or proxy statements, but rather serves as a formal notice of the procedural steps for the meeting. Given it is a regulatory notification regarding meeting logistics, it falls under the RNS category.
2022-12-15 Korean
[기재정정]분기보고서 (2022.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'PharmAbcine' (주)파멥신, covering the period from January 1, 2022, to September 30, 2022. It contains detailed financial information, business descriptions, and management disclosures, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2022
2022-11-14 Korean
분기보고서 (2022.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company PharmAbcine (주식회사 파멥신) covering the period from January 1, 2022, to September 30, 2022. It contains detailed corporate information, management discussion, capital structure, and business operations, which is characteristic of a formal interim financial report filed with the Korean financial authorities (Financial Supervisory Service/Korea Exchange). 9M 2022
2022-11-11 Korean
반기보고서 (2022.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for the company PharmAbcine, covering the period from January 1, 2022, to June 30, 2022. It contains detailed financial information, business operations, management discussions, and corporate governance details, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2022
2022-08-16 Korean
전환가액의조정
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing regarding the adjustment of the conversion price of convertible bonds (specifically, a 'Conversion Price Adjustment' notice). This type of filing relates to changes in the company's capital structure and financial instruments. Among the provided categories, 'Capital/Financing Update' (CAP) is the most accurate fit as it covers updates on financing activities and capital structure changes, including adjustments to convertible securities.
2022-07-15 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.